These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7784226)

  • 1. Genetics in cancer prediction, screening, and counseling: Part I, Genetics in cancer prediction and screening.
    Loescher LJ
    Oncol Nurs Forum; 1995 Mar; 22(2 Suppl):10-5. PubMed ID: 7784226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics in cancer prediction, screening, and counseling: Part II, The nurse's role in genetic counseling.
    Loescher LJ
    Oncol Nurs Forum; 1995 Mar; 22(2 Suppl):16-9. PubMed ID: 7784227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA testing for cancer predisposition.
    Loescher LJ
    Oncol Nurs Forum; 1998 Sep; 25(8):1317-27. PubMed ID: 9766286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically linked cancers: prevention, detection, and treatment.
    McMillan SC
    J Intraven Nurs; 1996; 19(6):321-8. PubMed ID: 9060359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer genetics.
    Chapman DD
    Semin Oncol Nurs; 2007 Feb; 23(1):2-9. PubMed ID: 17303511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary neoplastic diseases (genetic predisposition and cancer syndromes)].
    Oláh E
    Orv Hetil; 1999 Feb; 140(9):451-66. PubMed ID: 10204401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary cancer syndrome: Part 1.--Clinical and educational issues.
    Mahon SM; Casperson DS
    Oncol Nurs Forum; 1995 Jun; 22(5):763-71. PubMed ID: 7675683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetics and cancer: advances and perspectives].
    Kahn A
    Pathol Biol (Paris); 1995 Mar; 43(3):139-42. PubMed ID: 7675539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial pancreatic cancer: a review.
    Lynch HT; Smyrk T; Kern SE; Hruban RH; Lightdale CJ; Lemon SJ; Lynch JF; Fusaro LR; Fusaro RM; Ghadirian P
    Semin Oncol; 1996 Apr; 23(2):251-75. PubMed ID: 8623061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial (hereditary) cancer].
    Maekawa M
    Rinsho Byori; 2002 Nov; Suppl 123():121-30. PubMed ID: 12652799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of breast cancer.
    Morrison BW
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):15-27. PubMed ID: 8150776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-susceptibility markers.
    Bellet D
    J Natl Cancer Inst Monogr; 1992; (12):115-21. PubMed ID: 1616794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy.
    Spandidos DA; Liloglou T; Field JK
    Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
    Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
    CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.